Voriconazole: A second-generation triazole

P. H. Chandrasekar, Elias Kurian Manavathu

Research output: Contribution to journalReview article

96 Citations (Scopus)

Abstract

Voriconazole, a derivative of fluconazole, is an antifungal triazole with expanded spectrum of activity against a variety of yeasts and filamentous fungi. It exhibits fungicidal activity against Aspergillus species. Preliminary data from animal models and clinical trials show promise in the treatment of candidiasis and aspergillosis. Of concern is the development of resistance to voriconazole and cross-resistance with other azoles. Voriconazole is a welcome addition to our limited armamentarium against potentially fatal fungal infections.

Original languageEnglish (US)
Pages (from-to)135-148
Number of pages14
JournalDrugs of Today
Volume37
Issue number2
DOIs
StatePublished - Jan 1 2001

Fingerprint

Triazoles
Azoles
Aspergillosis
Mycoses
Fluconazole
Candidiasis
Aspergillus
Fungi
Animal Models
Yeasts
Clinical Trials
Voriconazole

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Chandrasekar, P. H., & Manavathu, E. K. (2001). Voriconazole: A second-generation triazole. Drugs of Today, 37(2), 135-148. https://doi.org/10.1358/dot.2001.37.2.614849

Voriconazole : A second-generation triazole. / Chandrasekar, P. H.; Manavathu, Elias Kurian.

In: Drugs of Today, Vol. 37, No. 2, 01.01.2001, p. 135-148.

Research output: Contribution to journalReview article

Chandrasekar, PH & Manavathu, EK 2001, 'Voriconazole: A second-generation triazole', Drugs of Today, vol. 37, no. 2, pp. 135-148. https://doi.org/10.1358/dot.2001.37.2.614849
Chandrasekar, P. H. ; Manavathu, Elias Kurian. / Voriconazole : A second-generation triazole. In: Drugs of Today. 2001 ; Vol. 37, No. 2. pp. 135-148.
@article{03a5074be32241a5ae471e77abd35b3f,
title = "Voriconazole: A second-generation triazole",
abstract = "Voriconazole, a derivative of fluconazole, is an antifungal triazole with expanded spectrum of activity against a variety of yeasts and filamentous fungi. It exhibits fungicidal activity against Aspergillus species. Preliminary data from animal models and clinical trials show promise in the treatment of candidiasis and aspergillosis. Of concern is the development of resistance to voriconazole and cross-resistance with other azoles. Voriconazole is a welcome addition to our limited armamentarium against potentially fatal fungal infections.",
author = "Chandrasekar, {P. H.} and Manavathu, {Elias Kurian}",
year = "2001",
month = "1",
day = "1",
doi = "10.1358/dot.2001.37.2.614849",
language = "English (US)",
volume = "37",
pages = "135--148",
journal = "Drugs of Today",
issn = "1699-3993",
publisher = "Prous Science",
number = "2",

}

TY - JOUR

T1 - Voriconazole

T2 - A second-generation triazole

AU - Chandrasekar, P. H.

AU - Manavathu, Elias Kurian

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Voriconazole, a derivative of fluconazole, is an antifungal triazole with expanded spectrum of activity against a variety of yeasts and filamentous fungi. It exhibits fungicidal activity against Aspergillus species. Preliminary data from animal models and clinical trials show promise in the treatment of candidiasis and aspergillosis. Of concern is the development of resistance to voriconazole and cross-resistance with other azoles. Voriconazole is a welcome addition to our limited armamentarium against potentially fatal fungal infections.

AB - Voriconazole, a derivative of fluconazole, is an antifungal triazole with expanded spectrum of activity against a variety of yeasts and filamentous fungi. It exhibits fungicidal activity against Aspergillus species. Preliminary data from animal models and clinical trials show promise in the treatment of candidiasis and aspergillosis. Of concern is the development of resistance to voriconazole and cross-resistance with other azoles. Voriconazole is a welcome addition to our limited armamentarium against potentially fatal fungal infections.

UR - http://www.scopus.com/inward/record.url?scp=0035073834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035073834&partnerID=8YFLogxK

U2 - 10.1358/dot.2001.37.2.614849

DO - 10.1358/dot.2001.37.2.614849

M3 - Review article

AN - SCOPUS:0035073834

VL - 37

SP - 135

EP - 148

JO - Drugs of Today

JF - Drugs of Today

SN - 1699-3993

IS - 2

ER -